Carbon-phosphorus stapled Au(i) anticancer agents via bisphosphine induced reductive elimination

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

Towards the goal of generating new stabilized gold complexes as potent anticancer agents, we report here a novel class of Au(i) agents from Au(iii)-mediated Caryl-P bond formation captured within the same complex by reacting a C^N cyclometalated Au(iii) complex with bisphosphines. Cyclometalated Au(iii) complexes of the type [Au(C^N)Cl2], where C^N represent different aryl pyridine framework reacted with bis(2-diphenylphosphino)phenyl ether in refluxing methanol to access an unsymmetrical gold complex featuring C-P coupling and Au(i)-phosphine. The complexes were characterized by 1H-NMR, 13C-NMR, and 31P-NMR and mass spectrometry. The structures of the complexes were characterized by X-ray crystallography and purity ascertained by HPLC and elemental analysis. The complexes demonstrate promising anticancer activity in a broad panel of cancer cell lines of different tumor origin. Mechanistically, the complexes induce apoptosis, generate mitochondrial ROS, depolarize mitochondrial membrane potential and modulate mitochondrial respiration in cancer cells. Overall, we developed a new structural class of Au(i) complexes with promising anticancer potential with potential utility in other applications.

Original languageEnglish
Pages (from-to)18974-18982
Number of pages9
JournalDalton Transactions
Volume53
Issue number47
DOIs
StatePublished - Aug 14 2024

Bibliographical note

Publisher Copyright:
© 2024 The Royal Society of Chemistry.

Funding

This work and S. G. A. was supported by grant R01CA258421-01 from the National Cancer Institute. The authors would like to appreciate the following research centres and facilities at the University of Kentucky for their help towards the completion of the research described in this article. The UK NMR Center supported by NSF (CHE-997738) and the UK X-ray facility supported by the MRI program from NSF (CHE-1625732). Mitostress experiments were carried out by support from the shared resource(s) of the University of Kentucky Markey Cancer Center (P30CA177558). The authors also acknowledge support of the Center for Pharmaceutical Research and Innovation (NIH P20GM130456) and UK Research Leadership Academy (RLA), Emerging Themes for Research Program.

FundersFunder number
Center for Pharmaceutical Research and Innovation, University of Kentucky
RLA
UK Research Leadership Academy
National Childhood Cancer Registry – National Cancer Institute
Neurosciences FoundationCHE-997738, CHE-1625732
National Institutes of Health (NIH)P20GM130456
University of Kentucky Markey Comprehensive Cancer CenterP30CA177558

    ASJC Scopus subject areas

    • Inorganic Chemistry

    Fingerprint

    Dive into the research topics of 'Carbon-phosphorus stapled Au(i) anticancer agents via bisphosphine induced reductive elimination'. Together they form a unique fingerprint.

    Cite this